Generative Bionics has brought its robot to an American media outlet. On September 1, the company’s CEO, Daniele Pucci, appeared on theCUBE, SiliconANGLE’s flagship program, which through NYSE Wired connects its Palo Alto studio with its New York counterpart. The interview, hosted by John Furrier, was part of a series dedicated to physical AI and robotics. Pucci joined from Brussels, where he was attending an event, and he was not alone: after about a minute of conversation, GENE.01 entered the frame and walked toward him.
The robot was developed in just six months. According to Pucci, the key enabling technology is the sense of touch: an in-house capacitive sensory skin that measures the deflection between two metal plates and covers the robot’s entire body. This is complemented by a proximity sensor that allows the machine to detect the presence of a person even before physical contact occurs. It is the combination of these two sensing layers, Pucci explained, that makes the difference for a robot designed to work alongside humans and sets it apart from what he sees as the dominant approach today.
“Those who talk about vision-language-action models for robots have too narrow a perspective. A robot is not only about vision and language. It is also about touch and force interaction.”
This philosophy shapes the company’s design methodology, which Pucci described in contrast to conventional practice. Typically, he explained, engineers first build the mechanical structure and only afterward hand it over to AI specialists. The result is often a suboptimal system—a robotic arm that weighs more than the task actually requires. Generative Bionics designs body and intelligence as a single integrated system, allowing the intended task to determine the robot’s morphology. After all, lifting a box and running demand very different weight distributions.
The company’s work relies on proprietary libraries that simulate biological evolution and generate robot variants inspired by biomechanics. This approach gave the company its name and, as Pucci joked, also introduces a practical constraint: “we have to make sure the robot we generate doesn’t end up with four legs and three arms.”
In a post published the following day, the company summarized the concept with a simple formula: the body shares the thinking. In other words, the robot’s physical structure contributes to problem-solving, reducing the computational burden that would otherwise be handled entirely by software.
The company’s commercial strategy follows the same principle. “We don’t solve useless problems” is the mantra Pucci repeated throughout the conversation. The process starts from industrial use cases, defining operational scenarios, collecting data, and only then moving toward more general-purpose models. Generative Bionics has identified five primary sectors: security and surveillance, retail, manufacturing, logistics, and healthcare.
There is also a constraint that, according to Pucci, is being largely overlooked across the industry:
“A humanoid robot that performs welding cannot be the same humanoid robot used in a hospital. And this is not just common sense, John. Regulations and certification requirements—which almost no company is taking into account right now—will not allow you to sell exactly the same robot to a shipyard and to the healthcare sector.”
For this reason, the company is developing a modular platform, both in hardware and software, from which industry-specific humanoids can be derived, each with different external designs, AI systems, hands, and feet.
The timeline revealed during the interview was among its most significant announcements. The first GENE.01 customized for welding is expected to be deployed at a Fincantieri shipyard during the first quarter of 2027. At the same time, the company is building what it describes as Europe’s largest humanoid robot manufacturing facility.
Pucci stated that certified safety remains the company’s top priority, as it is a prerequisite for large-scale deployment. The broader mission, however, remains unchanged: to amplify human capabilities rather than replace them. In an aging Europe, he argued, humanoid robots can help people address future challenges, beginning with elderly care and assistance.
At the end of 2025, Generative Bionics was still a humanoid robotics research initiative within the Italian Institute of Technology, the research organization that develops technologies for people from its campus on Genoa’s Erzelli hill. Today, it is a company discussing the future direction of global robotics on a leading American technology platform and working toward a concrete milestone: bringing its robot into a shipyard.
This is precisely the journey that a science and technology park exists to enable: research becoming enterprise, and enterprise returning to compete on the international stage.
